Erlanger Institute for Clinical Research

Chattanooga, Tennessee 37403

0 studies enrolling now · 3 studies all time

What they study most

Arthritis, Rheumatoid, Atrial Fibrillation, Cardiac Resynchronization Therapy, Heart Failure, Non-Small-Cell Lung Adenocarcinoma, Non-small Cell Lung Cancer Metastatic, Non-small Cell Lung Cancer Stage IIIB, Non-small Cell Lung Cancer Stage IV

Studies at this site

• INFINITY™ With ADAPTIS™ Technology Study — Running, not enrolling
• Atrial Fibrillation Associated With Heart Failure Treated by BIOTRONIK's CRT-DX System — Stopped early
• A Phase 3 Study of Ganetespib in Combination With Docetaxel Versus Docetaxel Alone in Patients With Advanced NSCLC — Stopped early